Wuxi AppTec Co Ltd 02359
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 02359 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- HKD 41.30
- Day Range
- HKD 38.70–42.65
- 52-Week Range
- HKD 32.60–103.60
- Bid/Ask
- HKD 41.15 / HKD 41.20
- Market Cap
- HKD 120.86 Bil
- Volume/Avg
- 17.3 Mil / 9.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 10.10
- Price/Sales
- 2.72
- Dividend Yield (Trailing)
- 2.40%
- Dividend Yield (Forward)
- 2.63%
- Total Yield
- 2.40%
Company Profile
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, gene therapies, and testing services for medical devices. Its segments comprise WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It generates the majority of its revenue from the WuXi Chemistry segment. Its geographic areas are the PRC, USA, Europe, and the Rest of the world, in which it generates the majority of its revenue from the USA.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Large Core
- Total Number of Employees
- 41,116
- Website
- https://www.wuxiapptec.com
Comparables
Valuation
|
Metric
|
02359
|
ACRS
|
300685
|
|---|---|---|---|
Price/Earnings (Normalized) | 10.10 | — | 30.40 |
Price/Book Value | 1.91 | 0.59 | 4.46 |
Price/Sales | 2.72 | 2.69 | 7.22 |
Price/Cash Flow | 8.50 | — | 25.05 |
Price/Earnings
02359
ACRS
300685
Financial Strength
|
Metric
|
02359
|
ACRS
|
300685
|
|---|---|---|---|
Quick Ratio | 1.84 | 3.86 | 13.42 |
Current Ratio | 2.33 | 4.16 | 13.97 |
Interest Coverage | 209.20 | — | 194.63 |
Quick Ratio
02359
ACRS
300685
Profitability
|
Metric
|
02359
|
ACRS
|
300685
|
|---|---|---|---|
Return on Assets (Normalized) | 13.74% | −36.39% | 11.25% |
Return on Equity (Normalized) | 18.79% | −47.28% | 12.34% |
Return on Invested Capital (Normalized) | 16.27% | −47.18% | 12.20% |
Return on Assets
02359
ACRS
300685
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Lxwjdqtmzt | Bdmc | $228.7 Bil | |
DHR
| Danaher Corp | Slstgkjn | Ykmgwd | $195.1 Bil | |
A
| Agilent Technologies Inc | Rsmxfcskh | Wwrwt | $45.2 Bil | |
IQV
| IQVIA Holdings Inc | Jglkmkdw | Tsjyf | $42.1 Bil | |
IDXX
| IDEXX Laboratories Inc | Bxsspgzjv | Xwbmby | $41.5 Bil | |
MTD
| Mettler-Toledo International Inc | Nxshrpxnf | Yzcsqhd | $32.5 Bil | |
ICLR
| Icon PLC | Rjmpynww | Vgxpjgj | $26.6 Bil | |
WAT
| Waters Corp | Wswnbdpcdz | Whw | $21.5 Bil | |
ILMN
| Illumina Inc | Bmjdghj | Lglmhkw | $18.3 Bil | |
LH
| Laboratory Corp of America Holdings | Cymphlyhz | Xdhxq | $18.0 Bil |